Amikacin Inj.

This amikacin injection material, supplied by China National Pharmaceutical Foreign Trade Corporation (which sources rather than manufactures it), meets a purity of not less than 99.0% by HPLC, with a stated production scale of several hundred kilograms per month and a DMF available. It is distributed to markets across North America, Europe, Australasia, Asia, the Middle East, and Africa.